CEVAC - Ghent University and Ghent University Hospital

CEVAC - Ghent University and Ghent University Hospital is rated 3 out of 5 in the category research. Read and write reviews about CEVAC - Ghent University and Ghent University Hospital. CEVAC contributes to the development of safe and effective vaccines to prevent and/or treat diseases. In the past decades, CEVAC was involved in the development and evaluation of vaccines against hepatitis B virus, the first combined hepatitis A / B vaccine, a therapeutic vaccine against hepatitis C, cervical cancer vaccines, herpes simplex viruses, human immunodeficiency virus (HIV, AIDS), tuberculosis, flu, group B streptococcus, whooping-cough, RSV and others. Clinical unit At the Clinical Unit, participants of a vaccine studies will visit us for the planned study procedures. Most CEVAC studies are organizes on behalf of pharmaceutical companies: the clients or sponsors. All study procedures are executed in compliance with International Clinical Practice (GCP) standards. Laboratory unit In the dedicated Laboratory Unit (CEVAC Core Lab), biological samples obtained during clinical vaccine studies are pre-processed, analyzed with the most innovative immunomonitoring techniques and carefully stored to the highest quality standards.